The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-N-((2S,3R)-3-hydroxy-4-(N-isobutyl-4-nitrophenylsulfonamido)-1-phenylbutan-2-yl)acetamide ID: ALA4475878
PubChem CID: 155537777
Max Phase: Preclinical
Molecular Formula: C26H31FN6O7S
Molecular Weight: 590.63
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)Cn1cc(F)c(N)nc1=O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C26H31FN6O7S/c1-17(2)13-32(41(39,40)20-10-8-19(9-11-20)33(37)38)15-23(34)22(12-18-6-4-3-5-7-18)29-24(35)16-31-14-21(27)25(28)30-26(31)36/h3-11,14,17,22-23,34H,12-13,15-16H2,1-2H3,(H,29,35)(H2,28,30,36)/t22-,23+/m0/s1
Standard InChI Key: JMIQDUFANYKBGP-XZOQPEGZSA-N
Molfile:
RDKit 2D
41 43 0 0 0 0 0 0 0 0999 V2000
22.9144 -18.8160 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
22.2127 -19.2288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6675 -18.8408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4987 -18.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3815 -19.2453 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.6243 -19.2205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7930 -19.2411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0872 -18.8367 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4934 -18.1020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3188 -18.1020 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2127 -20.0459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6633 -18.0236 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.0831 -18.0154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6243 -20.0377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3218 -18.8078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0358 -20.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7971 -20.0583 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7498 -20.4298 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7847 -17.6068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3341 -20.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0316 -19.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6090 -20.7641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7806 -16.7896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4946 -18.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1880 -21.4616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4220 -20.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2004 -17.5944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4822 -16.3727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1962 -16.7772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9625 -19.2541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2521 -18.8502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2489 -18.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5426 -17.6294 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.8352 -18.0392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8386 -18.8574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5495 -19.2657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9549 -17.6218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1263 -17.6326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4535 -20.0116 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.7601 -21.2483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1322 -19.2682 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 5 1 0
4 2 1 0
5 8 1 0
6 1 1 0
7 4 1 0
8 7 1 0
9 1 2 0
10 1 2 0
11 2 1 0
12 3 2 0
8 13 1 1
14 6 2 0
15 6 1 0
16 20 2 0
7 17 1 1
18 16 1 0
19 13 1 0
20 14 1 0
21 15 2 0
22 11 1 0
23 19 1 0
24 19 2 0
25 22 1 0
26 22 1 0
27 24 1 0
28 23 2 0
29 28 1 0
21 16 1 0
29 27 2 0
3 30 1 0
30 31 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 2 0
34 35 1 0
35 36 2 0
32 37 2 0
34 38 1 0
18 39 2 0
18 40 1 0
35 41 1 0
M CHG 2 18 1 40 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 590.63Molecular Weight (Monoisotopic): 590.1959AlogP: 1.31#Rotatable Bonds: 13Polar Surface Area: 190.76Molecular Species: NEUTRALHBA: 10HBD: 3#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.12CX Basic pKa: ┄CX LogP: 1.56CX LogD: 1.56Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.19Np Likeness Score: -1.07
References 1. Zhu M, Ma L, Zhou H, Dong B, Wang Y, Wang Z, Zhou J, Zhang G, Wang J, Liang C, Cen S, Wang Y.. (2020) Preliminary SAR and biological evaluation of potent HIV-1 protease inhibitors with pyrimidine bases as novel P2 ligands to enhance activity against DRV-resistant HIV-1 variants., 185 [PMID:31734023 ] [10.1016/j.ejmech.2019.111866 ]